Literature DB >> 10551739

Immunohistochemical evaluation of Fhit protein expression in oral squamous cell carcinomas.

W F van Heerden1, T J Swart, M B van Heerden, E J van Rensburg, S Engelbrecht, L Dreyer, K Huebner.   

Abstract

The expression of Fhit (fragile histidine triad) protein in oral squamous cell carcinoma (OSCC) and adjacent oral epithelium was evaluated by immunohistochemistry on formalin-fixed paraffin-embedded blocks of 32 cases of OSCC. Rabbit polyclonal anti-GST-Fhit antiserum at 1:600 was used, after antigen enhancement in a microwave pressure cooker, in a saturated lead thiocyanate solution. This antiserum has been shown specifically to detect human Fhit by immunohistochemistry at dilutions up to 1:10,000. The Fhit protein expression was evaluated using both the intensity and extent of staining. Normal stratified squamous epithelium showed strong positivity, especially in the stratum spinosum and areas of keratinisation. Basal and parabasal cells were negative or expressed low levels of Fhit relative to the squamous epithelium. Mild and moderate epithelial dysplasia showed Fhit expression in the superficial layers, while Fhit expression was absent from severely dysplastic lesions. A reduction or loss of Fhit expression was found in 21 (66%) of the OSCC. The alterations in Fhit protein expression in OSCC, and not in normal tissues, are consistent with the proposal that Fhit inactivation plays a role in oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551739     DOI: 10.1111/j.1600-0714.1999.tb02102.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Muir-Torre-like syndrome in Fhit-deficient mice.

Authors:  L Y Fong; V Fidanza; N Zanesi; L F Lock; L D Siracusa; R Mancini; Z Siprashvili; M Ottey; S E Martin; T Druck; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.

Authors:  F Andriani; P Perego; N Carenini; G Sozzi; L Roz
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

4.  Mammalian nitrilase 1 homologue Nit1 is a negative regulator in T cells.

Authors:  Haibing Zhang; Ying-Ju Hou; Shuang-Yin Han; Eric C Zhang; Kay Huebner; Jianke Zhang
Journal:  Int Immunol       Date:  2009-04-24       Impact factor: 4.823

5.  The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted FHIT alleles.

Authors:  Stefano Volinia; Teresa Druck; Carolyn A Paisie; Morgan S Schrock; Kay Huebner
Journal:  Oncotarget       Date:  2017-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.